Biochemical purification of simvastatin
CA 2129661 C · Owner: Cianciosi, Steven J. · Inventors: Conder, Michael J.; Pisk, Eric T.; Tewalt, Gregory L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In the synthesis of simvastatin by direct methylation of lovastatin selective , hydrolysis of residual lovastatin lovastatin acid, or a salt thereof by treatment with a bacterium or fungus capable of hydrolyzing the 2-methyl-butyryloxy side chain or a mutant of such microbe or a cell-free extract derived therefrom or a hydrolase , derived therefrom yields 7-1',2',6',7',8',8a'(R)-hexahydro- 2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)naphthyl-3(R),5(R)-dihydroxyheptanoic acid, the triol acid, or triol salt which can be easily separated from simvastatin, either before or after lactonization to the lactone form. This process produces simvastatin of high yield and purity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 29, 1993 and granted July 31, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 29, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 29, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.